These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
67 related articles for article (PubMed ID: 35411366)
1. High-throughput design of symmetrical dimeric SARS-CoV-2 main protease: structural and physical insights into hotspots for adaptation and therapeutics. Padhi AK; Tripathi T Phys Chem Chem Phys; 2022 Apr; 24(16):9141-9145. PubMed ID: 35411366 [TBL] [Abstract][Full Text] [Related]
2. Targeted design of drug binding sites in the main protease of SARS-CoV-2 reveals potential signatures of adaptation. Padhi AK; Tripathi T Biochem Biophys Res Commun; 2021 May; 555():147-153. PubMed ID: 33813274 [TBL] [Abstract][Full Text] [Related]
3. Regulation of the Dimerization and Activity of SARS-CoV-2 Main Protease through Reversible Glutathionylation of Cysteine 300. Davis DA; Bulut H; Shrestha P; Yaparla A; Jaeger HK; Hattori SI; Wingfield PT; Mieyal JJ; Mitsuya H; Yarchoan R mBio; 2021 Aug; 12(4):e0209421. PubMed ID: 34399606 [TBL] [Abstract][Full Text] [Related]
4. Interface design of SARS-CoV-2 symmetrical nsp7 dimer and machine learning-guided nsp7 sequence prediction reveals physicochemical properties and hotspots for nsp7 stability, adaptation, and therapeutic design. Yadav AJ; Kumar S; Maurya S; Bhagat K; Padhi AK Phys Chem Chem Phys; 2024 May; 26(18):14046-14061. PubMed ID: 38686454 [TBL] [Abstract][Full Text] [Related]
5. A Structural Comparison of SARS-CoV-2 Main Protease and Animal Coronaviral Main Protease Reveals Species-Specific Ligand Binding and Dimerization Mechanism. Ho CY; Yu JX; Wang YC; Lin YC; Chiu YF; Gao JY; Lai SJ; Chen MJ; Huang WC; Tien N; Chen Y Int J Mol Sci; 2022 May; 23(10):. PubMed ID: 35628479 [TBL] [Abstract][Full Text] [Related]
6. Hotspot residues and resistance mutations in the nirmatrelvir-binding site of SARS-CoV-2 main protease: Design, identification, and correlation with globally circulating viral genomes. Padhi AK; Tripathi T Biochem Biophys Res Commun; 2022 Nov; 629():54-60. PubMed ID: 36113178 [TBL] [Abstract][Full Text] [Related]
7. Targeting the Dimerization of the Main Protease of Coronaviruses: A Potential Broad-Spectrum Therapeutic Strategy. Goyal B; Goyal D ACS Comb Sci; 2020 Jun; 22(6):297-305. PubMed ID: 32402186 [TBL] [Abstract][Full Text] [Related]
8. Structural and energetic features of the dimerization of the main proteinase of SARS-CoV-2 using molecular dynamic simulations. Zhang Y; Zheng L; Yang Y; Qu Y; Li YQ; Zhao M; Mu Y; Li W Phys Chem Chem Phys; 2022 Feb; 24(7):4324-4333. PubMed ID: 35107451 [TBL] [Abstract][Full Text] [Related]
9. Identification of mutation resistance coldspots for targeting the SARS-CoV2 main protease. Krishnamoorthy N; Fakhro K IUBMB Life; 2021 Apr; 73(4):670-675. PubMed ID: 33749986 [TBL] [Abstract][Full Text] [Related]
10. Innate immune evasion mediated by picornaviral 3C protease: Possible lessons for coronaviral 3C-like protease? Ng CS; Stobart CC; Luo H Rev Med Virol; 2021 Sep; 31(5):1-22. PubMed ID: 33624382 [TBL] [Abstract][Full Text] [Related]
11. SARS-CoV-2 M Grifagni D; Calderone V; Giuntini S; Cantini F; Fragai M; Banci L Chem Commun (Camb); 2021 Aug; 57(64):7910-7913. PubMed ID: 34278402 [TBL] [Abstract][Full Text] [Related]
12. Development of a Fluorescence-Based, High-Throughput SARS-CoV-2 3CL Froggatt HM; Heaton BE; Heaton NS J Virol; 2020 Oct; 94(22):. PubMed ID: 32843534 [TBL] [Abstract][Full Text] [Related]
13. 2-Pyridone natural products as inhibitors of SARS-CoV-2 main protease. Forrestall KL; Burley DE; Cash MK; Pottie IR; Darvesh S Chem Biol Interact; 2021 Feb; 335():109348. PubMed ID: 33278462 [TBL] [Abstract][Full Text] [Related]
18. Identification of Host Cellular Protein Substrates of SARS-COV-2 Main Protease. Miczi M; Golda M; Kunkli B; Nagy T; Tőzsér J; Mótyán JA Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33333742 [TBL] [Abstract][Full Text] [Related]
19. Identification of saquinavir as a potent inhibitor of dimeric SARS-CoV2 main protease through MM/GBSA. Bello M; Martínez-Muñoz A; Balbuena-Rebolledo I J Mol Model; 2020 Nov; 26(12):340. PubMed ID: 33184722 [TBL] [Abstract][Full Text] [Related]
20. SARS-CoV-2 proteases PLpro and 3CLpro cleave IRF3 and critical modulators of inflammatory pathways (NLRP12 and TAB1): implications for disease presentation across species. Moustaqil M; Ollivier E; Chiu HP; Van Tol S; Rudolffi-Soto P; Stevens C; Bhumkar A; Hunter DJB; Freiberg AN; Jacques D; Lee B; Sierecki E; Gambin Y Emerg Microbes Infect; 2021 Dec; 10(1):178-195. PubMed ID: 33372854 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]